Niger

Reimbursed Care Access

Niger is a party to the international drug control conventions and, in practice, classical psychedelic compounds (psilocybin, MDMA, DMT, mescaline, etc.) are treated as strictly controlled substances with no authorized outpatient/psychiatric medical programs or public reimbursement pathways. Ketamine is available and used as an essential injectable anesthetic in Niger’s health system, but there is no evidence of registered/esketamine psychiatric products or reimbursed psychedelic therapy programs in national public insurance.